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Double whammy
Recent developments in the treatment of metastatic mela-
noma have included immune checkpoint–blocking anti-
bodies, such as the anticytotoxic T-lymphocyte-associated 
antigen 4 antibody ipilimumab, as well as antiprogrammed 
death 1 antibodies, such as nivolumab. Because these 
agents have exhibited complementary activity in previ-
ous phase II studies, Larkin and colleagues conducted 
a randomized, double-blind, multicenter, phase III trial 
to evaluate the safety and efficacy of nivolumab alone or 
nivolumab combined with ipilimumab in patients with 
previously untreated metastatic melanoma. Treatment 
with nivolumab alone or in combination with  ipilimumab 
induced longer progression-free survival and higher 
objective response rates than treatment with ipilimumab 
alone. The progression-free survival observed for the 
combination therapy was in line with that reported fol-
lowing combined BRAF and MEK inhibition. Moreover, 
although a high percentage of patients experienced 
adverse events, management of these events was mostly 
successful, highlighting the potential for safe use of this 
combination therapy in a broad range of clinical settings. 
(N Engl J Med 373:23–34, 2015)  Selected by P. Nghiem
Antigen-specific twins
Both resident memory T (Trm) cells, which reside in 
peripheral tissues, and central memory T (Tcm) cells, 
which reside in lymph nodes, play a role in protective 
immunity; however, the origins of these distinct cell types 
remain unclear. Gaide and colleagues employed skin 
immunization with a contact sensitizer hapten, a protein, 
and a virus to probe the cell origins of Trm and Tcm cells 
in mice. The tissue Trm cell compartment responded rap-
idly in a tissue-specific response to antigen. The Tcm com-
partment gained effector function more slowly, although 
these cells were competent to supplement the Trm cells 
after antigen challenge. CDR3 sequence analysis supports 
the existence of a naive T-cell precursor common to Trm 
and Tcm cells. Together, these findings suggest that, after 
skin immunization, TCR-identical, antigen-reactive T cells 
are distributed to both lymph nodes as Tcm and to periph-
eral tissues as Trm cells to yield two distinct memory 
T-cell compartments with identical antigen specificity but 
unique effector characteristics. (Nat Med 21:647–53, 2015) 
Selected by T. Schwarz
Skin-resident bacteria calibrate immunity
An immune presence in the skin is essential for maintain-
ing an effective barrier to pathogens, but this homeostasis 
occurs with continuous contact with a diverse commen-
sal microbiota. Naik and colleagues recently reported 
that the skin represents a highly dynamic immune envi-
ronment that is actively and finely calibrated by defined 
commensal species. Tissue-resident dendritic cells 
were identified as the primary sensors of fluctuations 
in the commensal bacterial community and ultimately 
coordinate the generation of commensal-specific T-cell 
responses, providing a powerful protective mechanism 
for host defense via establishment of heterologous immu-
nity against potentially invasive microbes. These findings 
are intriguing in the context of skin diseases because 
commensal-specific immune responses were found to 
rely on the production of IL-17A, which contributes to 
the etiology and pathology of various skin inflamma-
tory disorders, such as psoriasis. (Nature 520:104–8, 2015) 
Selected by T. Schwarz
After the sun goes down
Although melanin offers protection from sunlight-induced 
DNA damage and skin cancer, this pigment is not neces-
sarily beneficial. Most mutations in human melanomas 
exhibit cyclobutane pyrimidine dimers (CPDs) that arise 
mainly from UVB exposure because UVA is less likely to 
generate these signature lesions. Premi and colleagues, 
however, recently found that exposure of melanin-con-
taining cells to UVA radiation induces reactive oxygen and 
nitrogen species that degrade melanin, induce the appear-
ance of melaninlike granules in the nucleus, and excite 
melanin derivatives to a triplet state with the high energy 
of a UV photon. Furthermore, these effects occur for many 
hours after the original UV exposure, allowing these excit-
ed products to essentially create CPDs in the dark. Thus, 
melanin may be carcinogenic as well as protective against 
melanoma. These mechanistic findings provide an avenue 
for exploration of novel triplet quenchers that may pro-
vide an “evening after” sunscreen to halt the carcinogenic 
processes after UV exposure. (Science 347:842–7, 2015) 
Selected by T. Schwarz
Genomic classification
Prognosis is not favorable for patients with melanoma with 
regional metastases, despite the recent approval of inhibi-
tors that target the frequently mutated MAPK pathway. To 
illuminate the biological heterogeneity of melanoma with 
hopes of improving prognosis and spurring development 
of novel therapeutic interventions, researchers from the 
Cancer Genome Atlas program performed a systematic, 
multiplatform characterization of 333 cutaneous melano-
mas from 331 patients at the DNA, RNA, and protein lev-
els. The melanomas were classified based on identified 
significantly mutated genes into four main subtypes: BRAF, 
RAS, NF1, and Triple Wild-Type, which included tumors 
that lacked hot-spot mutations in BRAF, RAS, or NF1 but 
featured KIT mutations, local amplifications, and com-
plex structural rearrangements. Consensus hierarchical 
clustering analysis revealed three additional subclasses. 
Interestingly, although no significant outcome correla-
tion with genomic classification was found, postaccession 
survival of patients with regionally metastatic tumors was 
improved in the “immune” transcriptomic subclass. (Cell 
161:1681–96, 2015)  Selected by M. Amagai
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